Thomas Owley, MD Rush Medical Center
|
|
- Abraham Woods
- 5 years ago
- Views:
Transcription
1 Thomas Owley, MD Rush Medical Center
2 Disclosure No conflicts of interest or disclosures I will be discussing the following medications which are all off label: --risperidone, olanzapine, aripiprazole, ziprasidone, loxapine, methylphenidate, amphetamine salts, fluoxetine, paroxetine, fluvoxamine, sertraline, citalopram, escitalopram, melatonin, topiramate, clonidine, trazadone, secretin
3 Why study comorbidity? Parsing out comorbid disorders will help us to identify targets for interventions and improve quality of life for these children and their families Funding sources are endorsing this approach: Example: UIC ACE is studying a Insistence on sameness symptom:
4 Challenges to Studying Comorbidity in ASD As in MR/ID, children with ASD often have their symptoms attributed to their intellectual disabilities Symptom overlap or complicated symptom attribution may lead to viewing problems in multiple contexts (one person s oppositionality is another s rigidity or insistence on sameness)
5 Is there comorbidity in ASD? (Simonoff et al, JAACP; August 2008) Assessed 112 British children years old with ASD for comorbidity using the Child and Adolescent Psychiatric Assessment (CAPA) CAPA requires behavioral description of symptoms, which decreases the chance that symptoms of ASD would be double coded as symptoms of another disorder [ie repetitive language (ASD) being coded as excessive need for reassurance (Anxiety]
6 Is there comorbidity in ASD? (Simonoff et al, JAACP; August 2008) 112 children: 62 classic autistic disorder, 50 children with other PDDs All confirmed by ADI/ADOS 95% White British Mean IQ = 72.7 (19-124)
7 Is there comorbidity in ASD? (Simonoff et al, JAACP; August 2008) Yes, there is comorbidity: Overall, 79.8% had at least one additional diagnosis (Leyfer et al, JADD, 2006 =72%) 57% had more than one additional diagnosis (Leyfer = 50%)
8 Comorbid Anxiety Disorders (Simonoff, 2008) Overall w/any Anxiety d/o: 41.9% Social Anxiety Disorder: 29.2 Generalized Anxiety Disorder: 13.4% Panic Disorder: 10.1% Obsessive Compulsive Disorder: 8.2% * * = lower than others have found (Leyfer, 2006 = 37.2%); CAPA requires purposeful quality to obsess/compuls
9 Other Comorbid Disorders (Simonoff, 2008) ADHD: 28.2% (did not subtype) Oppositional Defiant Disorder: 28.1% Conduct Disorder: 3.2% Any Depressive D/O (MDD or Dysthymic D/O): 1.4% (Leyfer = 12%)
10 Other findings of interest (Simonoff, 2008) Consistent with other studies of ASD, no sex difference in rates of comorbid ADHD Lower rates of MDD rates in this study may reflect younger age Overall: there is lots of comorbidity
11 Whaddaya Mean By Off Label, Doc? Comorbid symptoms/disorders are the primary targets of most pharmacological interventions in ASD Only one medication with an indication for ASD, and that is for a very specific symptom, NOT a treatment for a core diagnostic criteria
12 Two Types of Treatment Type I: Treatment of Core Symptom --This is a treatment that is aimed at treating the primary (core) social and language problems in autism Examples: secretin, Alzheimer s medications --Rare, and usually done in the context of a study --No med has been shown to be useful for this indication thus far in controlled trials
13 Two Types of Treatments Type II: Treatment of Problem or Target Symptom Examples: amphetamine salts for hyperactivity, escitalopram for anxiety 95+% of what we do everyday; lots of evidence for usefulness
14 So how do we medicate? Two Concepts 1. Target Symptoms and 2. Risk/Benefit Ratio
15 First Concept: Target Symptoms Almost always, we don t treat autism Instead, we find target symptoms Target symptoms are: --symptoms that are causing significant difficulties --symptoms that we can expect to respond to medication
16 Target Symptoms Typical target symptoms that respond to medication --Irritability/Anxiety --Obsessions/Compulsions --Hyperactivity --Attention/Concentration --Aggression --Sleep difficulties
17 Target Symptoms Not great medication target symptoms (in addition to social/communication problems): Stereotypies and most stimming Narrow food interests Running away (unless hyperactivity-based) Self injurious behavior (SIB; although occasionally we do succeed)
18 Are kids with ASD taking medication? Yes: Martin (1999): 55% Lam (2002): 50.2% Aman (2003): 51.6% Oswald (2007): 57%
19 Pharmacology of Developmental Disorders Humbling work Little to guide us in the clinic --Paucity of controlled studies/open trials --Specifically relevant to this discussion, most comorbid disorders are considered trumped by autism --Incidence high enough to interest pharmaceutical industry? --Enough etiological information to develop a medication pipeline?
20 Complexity of Drug Trials in ASD Patients Extreme heterogeneity in presentation in terms of combinations of medical and psychiatric difficulties Communication problems may limit ability of patient to articulate presenting problems/side effects May be especially vulnerable to drug side effects
21 Before Considering Medication Optimize educational, behavioral, psychotherapeutic, vocational, and recreational programming (psychopharmacology is an adjunct to these primary interventions)
22 Are the ADHD symptoms ADHD symptoms or ASD symptoms? Inattention in ASD could also be: 1. Poor joint attention (social difficulty) 2. Restrictive attention or trouble shifting 3. Severe anxiety Hyperactivity in ASD could also be: 1. Severe anxiety 2. Frenetic stereotypies 3. Mania 4. Akathisia
23 Workup on Inattention in Kids with Autism Inattention Sub-Subtype I: Señor Decreased Social Valence Defining Characteristics: --doesn t listen when spoken to directly --not making eye contact with the teacher (but still performing) --changes subject to preferred interest --shows sustained attention and attention to detail in other tasks --doesn t follow through on instructions
24 Workup on Inattention in Kids with Autism Inattentive Sub-Subtype II: Señor Classic ADHD Defining characteristics: --Difficulty organizing tasks --Often loses things --Distracted by extraneous stimuli --Is often forgetful in daily activities
25 Workup on Inattention in Kids with Autism Inattentive Sub-Subtype III: Señor Nervioso Defining characteristics: --No sustained attention --Forgetful, scattered thinking --Socially Anxious, Obsessive, Rigid, Insistence on Sameness, Needs Reassurance, Phobic --Take his pulse
26 Treatment of Inattentive ASD Sub-Subtypes: Mapping on Substrate Senor Decreased Social Valence: Etiological information insufficient; unknown substrate Senor Classic ADHD: Best knowledge suggests substrate is dopamine and/or norepinephrine Senor Nervioso: Best knowledge of substrate is serotonin
27 Treatment of Inattentive ASD Sub-Subtypes Rx: Senor Decreased Social Valence: Rote social learning and social groups Rx: Senor Classic ADHD: Stimu/Atomox Rx: Senor Nervioso: Complicated. 1. I usually try an SSRI first. 2. Sometimes only need SSRI, sometimes need SSRI plus stimulant.
28 Treatment Myth: Stimulants worsen stereotypies and agitation in children with ASD to the extent that stimulant treatment is contraindicated
29 Rupp Multidose Crossover (2005)
30 Comparing MTH response in ASD (RUPP) and nonasd kids (MTA) Kids with ASD have a lower response rate (49%) vs. kids without ASD (69%) Kids with ASD do not tolerate MTH as well (18% with Adverse Events; mostly irritability) as kids without ASD (1.4%) But the take home is still: half the kids respond, which is substantial
31 Anecdotal Pearl Comorbid ADHD and Anxiety/OCD? Try an amphetamine product over methylphenidate: anecdotal experience and case studies suggest the possibility of decreases in anxiety in addition to decreases in ADHD symptoms (Insel et al 1983) (Owley et al 2002)
32 The Great Impersonator: Comorbidity and Anxiety in ASD Anxiety, in some form, often disguised, is common common common common common common common common common common common common common common common common common common common common common common common common common common common common in these kids
33 Serotonin and Autistic Disorder: Evidence for Involvement Hyperserotonemia: --Schain and colleagues [Freedman] (1961); replicated multiple times --Platelet-poor ultrafiltrates are not elevated in autism, suggesting increased serotonergic uptake or decreased serotonergic release (Cook, 1988; Cook and Leventhal, 1996)
34 Platelets and Serotonin
35 Serotonin and Autistic Disorder: Evidence for Involvement Tryptophan Depletion studies (McDougle, 1996) led to increase in stereotypical behaviors (rocking, whirling, anxiety) --(tryptophan 5-OH tryptophan serotonin) Finally, we have many positive open label and controlled trials of selective serotonin reuptake inhibitors in ASD
36 The Great Impersonator: Anxiety in ASD No matter what the parent presents as the primary symptom, see if it makes sense in the context of anxiety. This means: 1. Social difficulties (Core symptom or social phobia?) 2. Hyperactivity (ADHD or disorganizing anxiety?) 3. Aggression! (Without precipitant or mediated by rigidity and insistence on sameness?)
37 Problems with SSRI Treatment in Autistic Disorder Problem #1: Clinically, we see WIDE variablility in the final dose needed (and we are not aided by weight, gender, or age); in a related problem, some kids have dramatic side effects to even tiny doses Problem #2: Subsequently, many children are dosed too high in the community, do not benefit, and go on to try agents from other classes of medications with less palatable side effect profiles
38 How do we know when the dose is too high? Primary symptoms seen can include: --Irritability --Decreased need for sleep (consistently going to bed later and/or early morning awakening) --Aggressiveness --Excessive silliness or disinhibition --Mixed state
39 The Effect of Weight on Final Dose (Owley, 2005) Weight vs. Final Lexapro Dose Final Dose (Milligrams) Weight (Lbs)
40 The Effect of Age on Final Dose (Owley, 2005) Age vs. Final Lexapro Dose Final Dose (Milligrams) Age (Months)
41 Final Dose: Frequency and Cumulative % (Owley, 2005) Final Dose Frequency Cumulative %
42 Which SSRI in ASD? Fluoxetine Paroxetine Fluvoxamine Sertraline Citalopram Escitalopram
43 Cormorbid Medical Problems Important because they: Are common Ultimate behavioral manifestations may imitate/create psychiatric symptoms Are not always obvious in a population of children in which kids do not communicate well Are not always obvious in a population of kids with high pain thresholds
44 Cormorbid Medical Problems Otitis media GERD Dental Problems
45 Constipation Murch et al (2003): Studied 103 children with autism referred for GI assessment Rate of constipation was 36% Rate in unaffecteds going to the ER with GI pain was 10% Rate of mod/severe rectosigmoid loading or acquired megarectum was 54.5% vs. 24.1% of control subjects
46 Cormorbid Medical Problems Otitis media GERD Dental Problems
47 Sleep Difficulties in ASD Sleep-Wake cycle difficulties are well-established in autism including: --latency to sleep --early awakening --decreased overall sleep (the exceptions to these findings were studies that excluded meds or used young children)
48 Sleep Difficulties in ASD: Pharmacological Choices Three separate groups have shown reduced melatonin levels in children with autism (around 65% of kids with ASD) Melatonin is produced by the conversion of N- acetylserotonin to melatonin by acetylserotonin methyltransferase (ASMT) Are mutations and variants of ASMT the problem?
49 Melatonin
50 Melatonin (Garstang, et al 1997)
51 While we are on the topic, meds I wouldn t use in noncommunicative kids Trazadone Topiramate
52 Obesity A big problem
53 DD/MR and Weight Gain: Rimmer and Yamaki, 2006
54 Antipsychotic Family: Side Effect of Weight Gain The weight gain is especially troublesome in that it come from increase appetite; this leads to: 1. The usual long-term associated problems of obesity, including Type II diabetes, heart problems 2. Compounds other social problems 3. Issues over food may become the issues that are most problematic
55 Antipsychotic Family: Side Effect of Weight Gain Manufacturer s recommendations: For snacking, offer low-calorie/high-fiber foods such as rice cakes, carrots, celery, and popcorn Help your family member avoid fast foods-when your family must eat at a fast food restaurant, suggest a salad instead of a hamburger Provide positive reinforcement for sticking to a healthy diet Exercise All of which leads to
56 Antipsychotic Family: Side Effect of Weight Gain More weight gain since: Neither diet or exercise have any real chance of working Neither does giving other drugs that decrease appetite Real solution: start thinking about another medication
57 The Now What Problem risperidone/olanzapine (does very well but weight way up) Switch to aripiprazole (works but no change in weight). ziprasidone (doesn t work for this kid) Now what?
58 Now what? Just like visiting an old friend: Loxapine Why, you ask? --Loxapine is a mid-potency typical that acts like an atypical at low doses due to its affinity for not just D2 but also 5HT2 --low propensity to cause EPS (see Reinblatt et al 2006 for more info)
59 Even if you didn t ask for it, here it is: Permission On this day, _(date here), I give you permission to not have to do every single treatment that comes along. I give you permission to use your judgment regarding your choices for your child without suffering guilt from any person or group or nagging regrets from yourself for not instituting every single thing that is proposed on the Internet. Sincerely, Tom
3/19/2018. Cynthia King, MD Associate Professor of Psychiatry UNMSOM. Autism Spectrum Disorder
Cynthia King, MD Associate Professor of Psychiatry UNMSOM Autism Spectrum Disorder 1 Identify three behavioral health concerns in ASD Identify three common families of medication that may be supportive
More information3/19/2018. Cynthia King, MD Associate Professor of Psychiatry UNMSOM
Cynthia King, MD Associate Professor of Psychiatry UNMSOM 1 2 Autism Spectrum Disorder 3 Identify three behavioral health concerns in ASD Identify three common families of medication that may be supportive
More informationMedications for Anxiety & Behavior in Williams Syndrome. Disclosure of Potential Conflicts. None 9/22/2016. Evaluation
Medications for Anxiety & Behavior in Williams Syndrome Christopher J. McDougle, M.D. Director, Lurie Center for Autism Professor of Psychiatry and Pediatrics Massachusetts General Hospital and MassGeneral
More informationMedications in Autism: What We Know and Don't Know
Medications in Autism: What We Know and Don't Know Jeremy Veenstra-VanderWeele, M.D. Mortimer D. Sackler, M.D., Associate Professor Center for Autism and the Developing Brain Sackler Institute for Developmental
More informationComorbidity. Psychiatric Comorbidity
Rachel Loftin, Ph.D. Autism Assessment, Research & Treatment Services (AARTS) Rush University Medical Center Comorbidity Medical comorbidity Seizures GI (24% in one study) Infections Feeding Issues Etc.
More informationIndex. Note: Page numbers of article titles are in boldface type. A ADHD. See Attention-deficit/hyperactivity disorder (ADHD) b-adrenergic blockers
Note: Page numbers of article titles are in boldface type. A ADHD. See Attention-deficit/hyperactivity disorder (ADHD) a-adrenergic blockers for PTSD, 798 b-adrenergic blockers for PTSD, 798 Adrenergic
More information6/22/2012. Co-morbidity - when two or more conditions occur together. The two conditions may or may not be causally related.
Autism Spectrum Disorders and Co-existing Mental Health Issues By Dr. Karen Berkman Objective To present an overview of common psychiatric conditions that occur in persons with autism spectrum disorders
More informationTools that make a difference in mental health symptoms of autistic spectrum children Sumru Bilge-Johnson M.D. Program Director of Child Psychiatry
Tools that make a difference in mental health symptoms of autistic spectrum children Sumru Bilge-Johnson M.D. Program Director of Child Psychiatry Fellowship Associate Professor, Child Psychiatry NEOMED
More informationCHILD & ADOLESCENT PSYCHIATRY ALERTS, VOLUME XIV, 2012 INDEX
A Adderall Counterfeit, 31 addiction, internet CBT, 55 ADHD Adjunctive Guanfacine, 11 Counterfeit Adderall, 31 Developmental Trajectory and Risk Factors, 5 Dopamine Transporter Alterations, 14 Extended-Release
More informationAlpha-2 Agonists. Antipsychotics
Table 5: Randomized Controlled Trials of Psychotropic Medications in Children and Adolescents with ASD Agent Study Target Symptoms Dose Demographics Significant Side Clonidine Guanfacine Jaselskis et al.,
More informationRole of ADHD medication in children with autism spectrum disorder. Pieter Hoekstra University of Groningen, Netherlands
Role of ADHD medication in children with autism spectrum disorder Pieter Hoekstra University of Groningen, Netherlands Symptoms of ADHD are highly prevalent in children with ASD Two independent chart reviews
More information11/2/2016 INSIDE THE MIND OF A CHILD PSYCHIATRIST: PROBLEM BEHAVIORS IN CHILDREN WITH AUTISM FACULTY DISCLOSURE
FACULTY DISCLOSURE INSIDE THE MIND OF A CHILD PSYCHIATRIST: PROBLEM BEHAVIORS IN CHILDREN WITH AUTISM KristinDawson, MD Assistant Professor University of Kentucky No commercial conflicts of Interest Salary
More informationPediatric Psychopharmacology
Pediatric Psychopharmacology General issues to consider. Pharmacokinetic differences Availability of Clinical Data Psychiatric Disorders can be common in childhood. Early intervention may prevent disorders
More informationPiecing the Puzzle Together: Pharmacologic Approaches to Behavioral Management in Autism Spectrum Disorder
Piecing the Puzzle Together: Pharmacologic Approaches to Behavioral Management in Autism Spectrum Disorder Hannah Sauer, PharmD PGY1 Pediatric Pharmacy Resident Mayo Clinic 2015 MFMER slide-1 Objectives
More informationBob Klaehn, M.D. Bob Klaehn, M.D. October 3, /30/14
Bob Klaehn, M.D. October 3, 2014 1 Bob Klaehn, M.D. Medical Director, Arizona Division of Developmental Disabilities since 2001 Faculty, MIHS Child Psychiatry Residency Program Child Psychiatrist, District
More informationAutism/Pervasive Developmental Disorders Update. Kimberly Macferran, MD Pediatric Subspecialty for the Primary Care Provider December 2, 2011
Autism/Pervasive Developmental Disorders Update Kimberly Macferran, MD Pediatric Subspecialty for the Primary Care Provider December 2, 2011 Overview Diagnostic criteria for autism spectrum disorders Screening/referral
More information4/2/13 COMMON CLASSES OF MEDICATIONS. Child & Adolescent Behavioral Medicine & Medication Therapies. Behavioral Medicine & Medication Therapies
Child & Adolescent Behavioral Medicine & Medication Therapies Brian J Cowles, PharmD Associate Professor of Pharmacy Practice Albany College of Pharmacy & Health Sciences; Vermont Campus Behavioral Medicine
More informationAutism Spectrum Disorder and Mental Health Challenges in Youth
Autism Spectrum Disorder and Mental Health Challenges in Youth Management in the Primary Care Setting February 13, 2016 Rebecca Marshall, MD, MPH Outline DSM V Criteria Comorbidities Behavioral treatments
More informationPsychopharmacology of Autism Spectrum Disorder
Psychopharmacology of Autism Spectrum Disorder Christopher J. McDougle, MD Director, Lurie Center for Autism Professor of Psychiatry and Pediatrics Massachusetts General Hospital and MassGeneral Hospital
More informationThe Benefits and Limitations of Medication Treatment for Executive Dysfunctions and ADHD
The Benefits and Limitations of Medication Treatment for Executive Dysfunctions and ADHD Damon Korb, MD Behavioral and Developmental Pediatrician Director of the Center for Developing Minds Los Gatos,
More information23/06/2015. Absolutely none!!
Absolutely none!! Child and adolescent Mental Health can we help? Dr Tina Nicholson CCFP Family Practitioner and Medical Lead, Cochrane Clinical Lecturer Dept Family Med. U of C. Member of CanReach Faculty
More informationBrief Notes on the Mental Health of Children and Adolescents
Brief Notes on the Mental Health of Children and Adolescents The future of our country depends on the mental health and strength of our young people. However, many children have mental health problems
More informationObsessive/Compulsive Disorder
Obsessive/Compulsive Disorder An Overview of the Diagnosis, Symptoms, Assessment and Treatment in Behavioral Health Martin J. Harrington M.D., Staff Child/Adolescent Psychiatrist Children s Hospital and
More informationPsychiatry in Primary Care: What is the Role of Pharmacist?
Psychiatry in Primary Care: What is the Role of Pharmacist? Benjamin Chavez, PharmD, BCPP, BCACP Clinical Associate Professor Director of Behavioral Health Pharmacy Services January 12, 2019 Disclosure
More informationPharmacological management in children and adolescents with pervasive developmental disorder
Pharmacological management in children and adolescents with pervasive developmental disorder Min Sung, Daniel S. S. Fung, Yiming Cai, Yoon Phaik Ooi Objective: Pervasive developmental disorder (PDD) is
More informationPsychiatric Disorders and Treatments in Children with VCFS
Psychiatric Disorders in VCFS at Different Age Groups Psychiatric Disorders and Treatments in Children with VCFS Prof. Doron Gothelf, M.D. The Behavioral Neurogenetics Center Edmond & Lily Safra Children
More informationPsychiatric Disorders in Children and Adolescents D R P E Y M A N B A K H T I A R I A N C H I L D P S Y C H I A T R I S T M A Y 1 4 TH
Psychiatric Disorders in Children and Adolescents D R P E Y M A N B A K H T I A R I A N C H I L D P S Y C H I A T R I S T M A Y 1 4 TH 2 0 1 6 OUTLINE INTRODUCTION ANXIETY DISORDERS MOOD DISORDERS Depressive
More informationCHILD & ADOLESCENT PSYCHIATRY ALERTS, VOLUME XV, 2013 INDEX
A acceptance and commitment therapy Posttraumatic Stress, 69 ADHD Adjunctive Fatty Acids, 5 Adjunctive Guanfacine Pharmacokinetics, 27 Amantadine, 21 Atomoxetine, 23 Cancer Risk, 31 CBT for Comorbid Anxiety,
More informationPsychiatric Medications. Positive and negative effects in the classroom
Psychiatric Medications Positive and negative effects in the classroom Teaching the Medicated Child Beverly Bryant, M.D. Hattiesburg Clinic 9/17/14 Introduction According to the National Survey of Children
More informationWhat About Health 3: Challenging Behaviors
The title of this presentation is What About Health. I m. In this presentation I will discuss a number of health and mental health issues related to children with ASD. 1 Now I am going to switch to discussing
More informationAggression (Severe) in Children under Age 6
Aggression (Severe) in Children under Age 6 Level 0 Comprehensive diagnostic assessments. Refer to Principles of Practice on page 6. Evaluate and treat comorbid conditions (i.e. medical, other psychiatric
More informationChallenging ASD Cases November 11, Melanie Penner, MD, MSc, Mohammad Zubairi, MD, MEd,
Challenging ASD Cases November 11, 2017 Melanie Penner, MD, MSc, FRCPC @drmelpenner Mohammad Zubairi, MD, MEd, FRCPC @md_mszubairi Learning Objectives By the end of this workshop, participants will: 1)
More information2013 Virtual AD/HD Conference 1
Medication for & Coexisting Conditions Part 2 Dr. Kenny Handelman Child, Adolescent & Adult Psychiatrist Halton Healthcare Adjunct Professor of Psychiatry, University of Western Ontario www.drkenny.com
More informationAutism: Practical Tips for Family Physicians
Autism: Practical Tips for Family Physicians Keyvan Hadad, MD, MHSc, FRCPC Alberta College of Family Physicians 61st Annual Scientific Assembly March 5, 2016 No conflict of interest Diagnosis and Misdiagnosis
More informationGreen Tree / LaSalle Building Bridges, May 4, Behavior Management & Psychopharmacology in children with ASD. Page 1.
Behavior management and psychopharmacology in children with autism spectrum disorders James Coplan, MD Neurodevelopmental Pediatrics of the Main Line Rosemont, PA info@drcoplan.com (610) 520-2130 Disclosures
More informationWhat are the most common signs of ADHD? And what are the most common medication interventions?
What are the most common signs of ADHD? And what are the most common medication interventions? Bennett Gertz, MD, FAAP Developmental Behavioral Pediatrician Children s Developmental Health Services Albertina
More informationImproving Standards for Prescribing Psychotropic Medications in People with Intellectual and Developmental Disabilities
Disclosure Improving Standards for Prescribing Psychotropic Medications in People with Intellectual and Developmental Disabilities Jason Noel, Pharm.D., BCPP Lisa Hovermale, MD Drs. Noel and Hovermale
More informationUsing Drugs to Improve the Behavior of People with Autism: A Skeptical Appraisal. Alan Poling, Ph.D., BCBA-D Western Michigan University
Using Drugs to Improve the Behavior of People with Autism: A Skeptical Appraisal Alan Poling, Ph.D., BCBA-D Western Michigan University In a 2010 study of 60,641 children Mandell et al. found that: 56%
More informationAn Overview on the Use of Psychotropic Medications
An Overview on the Use of Psychotropic Medications Marilyn B. Benoit, M.D. Chief Clinical Officer SVP, Clinical & Professional Affairs Classes of Medications Antidepressants Anti-anxiety Mood stabilizers
More informationAutism: Improving Health Care Outcomes
AUTISM AWARESS CONFERENCE Lewis County Autism Coalition 23 September 2011 Autism: Improving Health Care Outcomes Glenn C. Tripp, M.D. Developmental Behavioral Pediatrics Medical Director, Developmental
More informationPaediatric Psychopharmacology. Dr Jalpa Bhuta. MD, DNB, MRCPsych (UK).
Paediatric Psychopharmacology. Dr Jalpa Bhuta. MD, DNB, MRCPsych (UK). Childhood pharmacokinetics Children have greater hepatic capacity More glomerular filtration Less fatty tissue Less ability to store
More informationOhio Psychotropic Medication Quality Improvement Collaborative. Minds Matter. Toolkit. for You and Your Family. This is the property of
Minds Matter Ohio Psychotropic Medication Quality Improvement Collaborative Minds Matter Toolkit for You and Your Family This is the property of About Minds Matter Minds Matter is a project to help teens,
More informationPrepared by: Elizabeth Vicens-Fernandez, LMHC, Ph.D.
Prepared by: Elizabeth Vicens-Fernandez, LMHC, Ph.D. Sources: National Institute of Mental Health (NIMH), the National Alliance on Mental Illness (NAMI), and from the American Psychological Association
More informationEffective Health Care Program
Comparative Effectiveness Review Number 43 Effective Health Care Program Off-Label Use of Atypical Antipsychotics: An Update Executive Summary Background Antipsychotics medications are approved by the
More informationTreatment of Autism Spectrum Disorder in Children and Adolescents
Evidence-Based Medicine Key Words: autism spectrum disorder, treatment, psychotherapy, psychopharmacology Treatment of Autism Spectrum Disorder in Children and Adolescents By Melissa DeFilippis, Karen
More informationSome difficulties experienced in ASD & ADHD
ADHD & ASD Nicola Ryan CAMHS Clinical Nurse Specialist and Child CBT Therapist Senior Lecturer in Mental Health Kingston University & St Georges University of London Private practice: www.nicolaryan.net
More informationBig Lots Behavioral Health. Prescribing Guidelines for Behavioral Health
Big Lots Behavioral Health Prescribing Guidelines for Behavioral Health Prescribing for Behavioral Health This document was developed by Nationwide Children s Hospital in conjunction with Partners For
More information2/23/18. Age of Anxiety: Transforming Qualms into Calm. Disclosures. Objectives. I have nothing to disclose
Age of Anxiety: Transforming Qualms into Calm Rosa Kim, MD Assistant Professor and Attending Child Psychiatrist Medical College of Wisconsin and Children s Hospital of Wisconsin Disclosures I have nothing
More informationLisa Goldstein, MD Child and Adolescent and Adult Psychiatrist
Lisa Goldstein, MD Child and Adolescent and Adult Psychiatrist Past President, Pennsylvania Branch of the International Dyslexia Association drlisa@lisagoldsteinmd.com April 2018 No disclosures, No conflicts.
More informationThat s Interesting Doc but my. ADHD and its Comorbidities. Jonathan E. Romain, Ph.D., ABPP-CN
That s Interesting Doc but my Kid ADHD and its Comorbidities Jonathan E. Romain, Ph.D., ABPP-CN Rationale Children with one diagnosis are more likely to have additional challenges (comorbidities) Children
More informationAugmentation and Combination Strategies in Antidepressants treatment of Depression
Augmentation and Combination Strategies in Antidepressants treatment of Depression Byung-Joo Ham, M.D. Department of Psychiatry Korea University College of Medicine Background The response rates reported
More informationBig Lots Behavioral Health. Prescribing Guidelines for Behavioral Health
Big Lots Behavioral Health Prescribing Guidelines for Behavioral Health Prescribing for Behavioral Health This document was developed by Nationwide Children s Hospital in conjunction with Partners For
More informationTo Give or not to Give Medication: That is the Question
To Give or not to Give Medication: That is the Question Charmi Patel Rao, MD September 14, 2018 Introduction Board Certified Child & Adolescent Psychiatrist Clinical expertise in ECMH and Developmental
More informationAntidepressant does not relieve repetitive behaviors
NEWS Antidepressant does not relieve repetitive behaviors BY KELLY RAE CHI 16 JUNE 2009 1 / 5 Bitter pill: Negative results from clinical trials of two antidepressants, Celexa and Prozac, challenge the
More informationTreatment Options for Bipolar Disorder Contents
Keeping Your Balance Treatment Options for Bipolar Disorder Contents Medication Treatment for Bipolar Disorder 2 Page Medication Record 5 Psychosocial Treatments for Bipolar Disorder 6 Module Summary 8
More informationPHARMACOLOGICAL THERAPY OF AUTISM SPECTRUM DISORDERS IN THE CLINICAL PRACTICE
ANTON et al. ORIGINAL PAPERS PHARMACOLOGICAL THERAPY OF AUTISM SPECTRUM DISORDERS IN THE CLINICAL PRACTICE Andra ISAC 2, Magdalena KWASIUK 1, Roxana ȘIPOȘ 1, Ioana MICLUȚIA 1, Viorel LUPU 1, Elena PREDESCU
More information11/11/2018. The ABCs of Medication Management for Autism Spectrum Disorder. ABC Logging (FBA) First. ABC Logging HOW TO COMPLEMENT BEHAVIORAL THERAPY
The ABCs of Medication Management for Autism Spectrum Disorder OR HOW TO COMPLEMENT BEHAVIORAL THERAPY ABC Logging (FBA) First We need to know what, when, where and why behaviors happen. Antecedent: What
More informationMental Health & Your Teen Tools, Strategies & Resources
3 rd Annual 22q11DS Family Conference Mental Health & Your Teen Tools, Strategies & Resources Dr. Claire De Souza Child & Adolescent Psychiatrist Medical Director, Consultation-Liaison Psychiatry Program
More informationTreat mood, cognition, and behavioral disturbances associated with psychological disorders. Most are not used recreationally or abused
Psychiatric Drugs Psychiatric Drugs Treat mood, cognition, and behavioral disturbances associated with psychological disorders Psychotropic in nature Most are not used recreationally or abused Benzodiazepines
More informationThe Autism Spectrum Disorders: Interventions
The Autism Spectrum Disorders: Interventions Isabelle Rapin Albert Einstein College of Medicine Bronx NY USA No Conflict of Interest Vienna, October 2007 Definitions Three terms I use interchangeably Autism
More informationNATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE Centre for Clinical Practice SCOPE
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE Centre for Clinical Practice 1 Guideline title SCOPE Autism: the management and support of children and young people on the autism spectrum 1.1 Short
More informationDevelopmental Disorders
Pharmacology of Pervasive Developmental Disorders W. David Lohr, M.D. Assistant Professor Child Psychiatry Bingham Child Guidance Center University of Louisville School of Medicine 502-852-1065 wdlohr01@louisville.edu
More informationFROM MEDICATION TO MINDFULNESS: NEW INSIGHTS INTO THE WORLD OF ANXIETY
13 th Pearl Leibovitch Clinical Day November 18th, 2014 Mounir H. Samy, MD, FRCP(C) Associate Professor of Psychiatry McGill University (ret.) FROM MEDICATION TO MINDFULNESS: NEW INSIGHTS INTO THE WORLD
More informationPSYCHIATRIC DRUGS. Mr. D.Raju, M.pharm, Lecturer
PSYCHIATRIC DRUGS Mr. D.Raju, M.pharm, Lecturer PSYCHIATRIC DRUGS Treat mood, cognition, and behavioral disturbances associated with psychological disorders Psychotropic in nature Most are not used recreationally
More informationMedically Accepted Indications for Pediatric Use of Psychotropic Medications by
Key: White Background: Medically Accepted Indication Yellow Backgroun: Medically Accepted Indication Status Not Ascertained Orange Background: Pediatric Indication cited, but not supported Red Background:
More informationReducing the Anxiety of Pediatric Anxiety Part 2: Treatment
Reducing the Anxiety of Pediatric Anxiety Part 2: Treatment Lisa Lloyd Giles, MD Medical Director, Behavioral Consultation, Crisis, and Community Services Primary Children s Hospital Associate Professor,
More informationJennifer Zarcone. Kennedy Krieger Institute and Johns Hopkins School of Medicine
Jennifer Zarcone Kennedy Krieger Institute and Johns Hopkins School of Medicine 1 2 Estimated that between 20% to 45% of people with autism and ID are taking psychotropic medication 14% 30% are taking
More informationDr Jane McCarthy Consultant Psychiatrist, East London NHS Foundation Trust & Visiting Senior Lecturer, Department of Forensic & Neurodevelopmental
Dr Jane McCarthy Consultant Psychiatrist, East London NHS Foundation Trust & Visiting Senior Lecturer, Department of Forensic & Neurodevelopmental Sciences Department, King s College London Prevalence
More informationTo do or not to do That is the question!
26/9/2 Dilemmas in prescribing in Developmental Disability Raja Mukherjee To misquote Shakespeare To do or not to do That is the question! Areas to consider Needs of Chidlren vs Adults Developmental disabilities
More informationInterventions for Autism: Translating Research into Practice
Interventions for Autism: Translating Research into Practice Cindy Canceko Llego, MD, MSc Developmental-Behavioral Pediatrician Clinical Epidemiologist Objectives To discuss the importance of good scientific
More informationObsessive and Compulsive Behavior in Huntington s Disease
Obsessive and Compulsive Behavior in Huntington s Disease Arik Johnson, PsyD HDSA Center of Excellence at UCLA June 21, 2014 29 th Annual HDSA Convention Louisville, KY Disclaimer The information provided
More informationMULTIPLE CHOICE. Choose the one alternative that best completes the statement or answers the question.
Abnormal Psychology Chapter 16: Disorders of Childhood and Adolescence Name MULTIPLE CHOICE. Choose the one alternative that best completes the statement or answers the question. 1) After her parents divorce,
More informationThings You Might Not Know About Psychotropic Medications But Wish You Did
Things You Might Not Know About Psychotropic Medications But Wish You Did John E. Dunne, MD December 3, 2016 PAL Conference Conflicts of Interest None to report I am employed by Seattle Children s and
More informationAutism Diagnosis and Management Update. Outline. History 11/1/2013. Autism Diagnosis. Management
Autism Diagnosis and Management Update Cathleen Small, PhD, BCBA-D Developmental Behavioral Pediatrics Maine Medical Partners Outline Autism Diagnosis Brief history New, DSM-5 diagnostic criteria Expressed
More informationEvidence-Based Pharmacotherapy. Emily Harris, MD, MPH, FAAP Cincinnati Children s Hospital Medical Center
Evidence-Based Pharmacotherapy Emily Harris, MD, MPH, FAAP Cincinnati Children s Hospital Medical Center CME Disclosure I have no personal financial relationships in any commercial interest related to
More informationDisclosures. Autism Society of Wisconsin. Case 2. Case 1. Case 3. Case 4 3/29/2018. Medication treatment for people with Autism Spectrum Disorder
Medication treatment for people with Autism Spectrum Disorder Autism Society of Wisconsin April 20, 2018 Richard P. Barthel, M.D. Disclosures In accordance with the ACCME policy on relevant financial disclosure,
More informationBehavioral Health. Behavioral Health. Prescribing Guidelines
Behavioral Health Behavioral Health Prescribing Guidelines Attention Deficit/Hyperactivity Disorder (ADHD) Start with a first line medication, either from the methylphenidate or dextroamphetamine-amphetamine
More informationAnswer Key for Case Studies. Grading for each case study. All Case Studies
Answer Key for Case Studies Grading for each case study All Case Studies *give 5 points for listing at least four accurate symptoms of the disorder *give 3 points for listing 2 symptoms of the disorder
More information6/20/2014. Medication in SMS: What s the evidence? What s reasonable? Management of Children with Developmental Disorders
Medication in SMS: What s the evidence? What s reasonable? Tom Challman, MD Medical Director Autism & Developmental Medicine Institute Geisinger Health System Management of Children with Developmental
More informationAutism Spectrum Disorders & Attention Deficit Disorder in PEDIATRIC PRIMARY CARE. Disclosures
Autism Spectrum Disorders & Attention Deficit Disorder in PEDIATRIC PRIMARY CARE TIPS Conference March 22, 2019 Benjamin L. Handen, PhD, BCBA-D Professor of Psychiatry and Pediatrics Western Psychiatric
More informationPediatrics Grand Rounds 9 April University of Texas Health Science Center at San Antonio. Overview. Prevalence of ASD (Cont.) Prevalence of ASD
9 April 200 Overview Diagnosis and Treatment of Autism Spectrum Disorders Steven R. Pliszka, M.D. Professor and Vice Chair Chief, Division of Child and Adolescent Psychiatry Department of Psychiatry The
More informationPrevalence of Comorbidity and Pattern Drug Use among Children with Attention-deficit hyperactivity disorder: A Single Center in Thailand
The 25th Federation Of Asian Pharmaceutical Association (FAPA) Congress 2014 Kota Kinabalu, Sabah, Malaysia 9th - 12th October, 2014 Prevalence of Comorbidity and Pattern Drug Use among Children with Attention-deficit
More informationMANAGING YOUR CHILD S PWS BEHAVIOR. What you wish they told you years ago!
MANAGING YOUR CHILD S PWS BEHAVIOR What you wish they told you years ago! VANDERBILT PRADER-WILLI SYNDROME LONGITUDINAL RESEARCH STUDY Aims: To phenotype behavior in 166 children and adults with PWS over
More informationSchedule FDA & literature based indications
Psychotropic Medication List Recommended dosages are intended to serve only as a guide for children. Recommended doses are literature based. Clinicians should consult package insert of medications for
More informationSUPPORT INFORMATION ADVOCACY
THE ASSESSMENT OF ADHD ADHD: Assessment and Diagnosis in Psychology ADHD in children is characterised by developmentally inappropriate overactivity, distractibility, inattention, and impulsive behaviour.
More informationJessica A. Hellings, MD, MB.BCh., M.Med Psych.
Autism Spectrum Disorders Jessica A. Hellings, MD, MB.BCh., M.Med Psych. Director Neurodevelopmental Psychiatry Study Program The Ohio State University Nisonger Center The Ohio State University Wexner
More informationObsessive-Compulsive Disorder Clinical Practice Guideline Summary for Primary Care
Obsessive-Compulsive Disorder Clinical Practice Guideline Summary for Primary Care CLINICAL ASSESSMENT AND DIAGNOSIS (ADULTS) Obsessive-Compulsive Disorder (OCD) is categorized by recurrent obsessions,
More informationABC Conference November 16, Behavior Management & Psychopharmacology James Coplan, MD. Page 3. Behavior.
Behavior management and psychopharmacology in children with autistic spectrum disorders James Coplan, MD Neurodevelopmental Pediatrics of the Main Line Rosemont, PA (610) 520-2130 11/16/2012 Learning Objectives
More informationParents Guide to ADHD Medications. Copyright Child Mind Institute
Copyright 2017. Child Mind Institute Children with attention-deficit hyperactivity disorder (ADHD) find it unusually difficult to concentrate on tasks, to pay attention, to sit still and to control impulsive
More informationIntroduction to Drug Treatment
Introduction to Drug Treatment LPT Gondar Mental Health Group www.le.ac.uk Introduction to Psychiatric Drugs Drugs and Neurotransmitters 5 Classes of Psychotropic medications Mechanism of action Clinical
More informationAtomoxetine. Open study showed 60% response of inattention and hyperactivity with a few much worse (Jou et al 2005)
Atomoxetine Open study showed 60% response of inattention and hyperactivity with a few much worse (Jou et al 2005) Buspirone Case reports (McCormick 1997, Hillbrand and Scott 1995,Realmuto et al 1989,
More information10/4/2018. Kelly Vinquist, PhD, BCBA Clinical Assistant Professor Co Director, ID MI program
Kelly Vinquist, PhD, BCBA Clinical Assistant Professor Co Director, ID MI program Mike Lind, PhD Clinical Assistant Professor Child Psychiatry Define challenging behaviors Understand the etiology of challenging
More informationA Brief Overview of Psychiatric Pharmacotherapy. Joel V. Oberstar, M.D. Chief Executive Officer
A Brief Overview of Psychiatric Pharmacotherapy Joel V. Oberstar, M.D. Chief Executive Officer Disclosures Some medications discussed are not approved by the FDA for use in the population discussed/described.
More informationAutism. Autism and autistic spectrum
Autism Autism is a disorder that affects the way a person communicates with and relates to other people. Most (but not all) people with autism also have a learning disability. People with autism need specialist
More informationObjectives. Co-Morbidity. Overview 4/19/16. Importance of Diagnosing Other Conditions. Difficulties with Dual Diagnosis. Caitlin Walsh, PhD 1
When it Isn t Just Autism: Co-Morbid Mental Health Conditions and ASD Caitlin Walsh, PhD Objectives 1. Report on prevalence of most common disorders that are co-morbid with ASD. 2. Identify difficulties
More informationGuide to Psychiatric Medications for Children and Adolescents
Guide to Psychiatric Medications for Children and Adolescents by Glenn S. Hirsch, M.D. The following guide includes most of the medications used to treat child and adolescent mental disorders. It lists
More informationPsychopharmacology for Non-MDs - Dr. Suzanne Dieter. March 10, 2017 PEDIATRIC PSYCHOPHARMACOLOGY FOR NON-MDS LEARNING OBJECTIVES
LEARNING OBJECTIVES PEDIATRIC PSYCHOPHARMACOLOGY FOR NON-MDS, MD New York, NY Member, American Academy of Child and Adolescent Psychiatry Understand the role a child psychiatrist can play as part of a
More informationASD (hyperactivity) 3 rd LINE TREATMENT Initial liquid dose mg 2. - ADHD symptoms without sleep
Generic Name Label Name Dosing by Disorder RITALIN, RITALIN LA, CONCERTA, METADATE ER, 2 ND LINE TREATMENT 2 ND LINE TREATMENT METADATE CD, MPH ER, Initial liquid dose 1-5 mg 1,2 Initial liquid dose 1-5mg
More informationADHD Part II: Managing Comorbities
ADHD Part II: Managing Comorbities Brett Johnson, MD Staff Psychiatrist Rady Children s Behavioral Crisis Center Assistant Clinical Professor (Voluntary), UCSD January 26, 2011 Financial Disclosure I have
More information